TITLE

Editorial: Non-Alcoholic Fatty Liver Disease After Liver Transplantation: A Case of Nurture and Nature

AUTHOR(S)
Ong, Janus; Younossi, Zobair M.
PUB. DATE
March 2010
SOURCE
American Journal of Gastroenterology;Mar2010, Vol. 105 Issue 3, p621
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. Most patients with cryptogenic cirrhosis are considered to have had “burned out NAFLD.” Although the recurrence and progression of NAFLD after liver transplantation (LT) have been shown previously, the incidence of de novo NAFLD after LT has not been extensively reported. In this issue of the American Journal of Gastroenterology, Dumortier et al. report the incidence of de novo post-LT NAFLD. Although most of the risk factors for post-LT NAFLD are similar to those for primary NAFLD, hepatic steatosis in the donor livers and a pre-transplant diagnosis of alcoholic liver disease remain independent risk factors. Although there are some limitations, this study provides the largest cohort of patients for whom post-LT NAFLD is reported.
ACCESSION #
48400307

 

Related Articles

  • The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Hartmann, Phillipp; Wei-Chung Chen; Schnabl, Bernd // Frontiers in Physiology;Sep2012, Vol. 3, preceding p1 

    Alcoholic liver disease (ALD) encompasses hepatic steatosis, which may progress to alcoholic hepatitis, fibrosis, and cirrhosis. It remains a leading cause of morbidity and mortality in the US and worldwide. The severity of liver disease correlates with plasma levels of bacterial products in...

  • Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Roulot, Dominique; Costes, Jean-Luc; Buyck, Jean-François; Warzocha, Ursula; Gambier, Nicolas; Czernichow, Sébastien; Le Clesiau, Hervé; Beaugrand, Michel // Gut;Jul2011, Vol. 60 Issue 7, p977 

    Background Liver stiffness measurement (LSM) has been used to measure fibrosis in patients with various types of chronic liver diseases. However, its usefulness as a screening procedure in apparently healthy people had not been evaluated to date. Methods 1358 subjects >45 years old from a...

  • The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease. Schuck, Robert N.; Zha, Weibin; Edin, Matthew L.; Gruzdev, Artiom; Vendrov, Kimberly C.; Miller, Tricia M.; Xu, Zhenghong; Lih, Fred B.; DeGraff, Laura M.; Tomer, Kenneth B.; Jones, H. Michael; Makowski, Liza; Huang, Leaf; Poloyac, Samuel M.; Zeldin, Darryl C.; Lee, Craig R. // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Fatty liver disease is an emerging public health problem without effective therapies, and chronic hepatic inflammation is a key pathologic mediator in its progression. Cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid to biologically active epoxyeicosatrienoic acids (EETs), which...

  • Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). Raszeja-Wyszomirska, Joanna; Szymanik, Barbara; Lawniczak, Malgorzata; Kajor, Maciej; Chwist, Alina; Milkiewicz, Piotr; Hartleb, Marek // BMC Gastroenterology;2010, Vol. 10, p67 

    Background: Nonalcoholic fatty liver disease (NAFLD) includes a wide spectrum of liver diseases, ranging from pure steatosis to nonalcoholic steatohepatitis (NASH), and eventually to liver cirrhosis with its complications. Identifying advanced fibrosis in patients is crucial to evaluating...

  • Recent advances in pathogenesis and management of pruritus in cholestatic liver disease. WANG Man; SUN Fengxia // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;nov2014, Vol. 30 Issue 11, p1208 

    Pruritus is one of the common clinical manifestations of cholestatic liver diseases such as primary biliary cirrhosis, primary sclerosing cholangitis, and intrahepatic cholestasis of pregnancy. Potential incentives of itching include bile salts, histamine, progesterone metabolites, endogenous...

  • Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of “Seed and Soil”. Dumortier, Jérôme; Giostra, Emiliano; Belbouab, Soraya; Morard, Isabelle; Guillaud, Olivier; Spahr, Laurent; Boillot, Olivier; Rubbia-Brandt, Laura; Scoazec, Jean-Yves; Hadengue, Antoine // American Journal of Gastroenterology;Mar2010, Vol. 105 Issue 3, p613 

    OBJECTIVES:Fatty liver disease is a potential long-term complication of liver transplantation (LT). We therefore aimed to determine the prevalence and risk factors of liver steatosis in a large population of adult post-LT patients.METHODS:We evaluated the clinical, biological, histological, and...

  • Nonalcoholic fatty liver disease.  // Mayo Clinic Health Letter;Sep2006, Vol. 24 Issue 9, p1 

    The article presents information on nonalcoholic fatty liver disease. Commonly referred as the silent liver disease, nonalcoholic fatty liver disease is a range of liver conditions which occurred in individuals who consumed little or no alcohol at all. The symptoms associated with nonalcoholic...

  • SERUM γ-GLUTAMYL-TRANSPEPTIDASE ISOFORMS IN ALCOHOLIC LIVER DISEASE. BELLINI, MASSIMO; TUMINO, EMANUELE; GIORDANI, ROBERTO; FABRINI, GIANCARLO; COSTA, FRANCESCO; GALUI, RENATO; RUCCO, MARCELLA; BELCARI, CLAUDIO; MICHELASSI, CLAUDIO; MURRI, LUIGI; MALTINTI, GIACOMO; MARCHI, SANTINO // Alcohol & Alcoholism;May1997, Vol. 32 Issue 3, p259 

    γ-Glutamyltranspeptidase (γGT) appears in serum in multiple forms; their significance and clinical utility in hepatobiliary and pancreatic diseases are still a matter of controversy. Electrophoretic separation of the multiple forms of γGT on agarose gel was performed in 20 alcoholic...

  • Prognostic Factors in Alcoholic Liver Disease. Chedid, Antonio; Mendenhall, Charles L.; Gartside, Peter; French, Samuel W.; Chen, Thomas; Rabin, Lionel // American Journal of Gastroenterology;Feb1991, Vol. 86 Issue 2, p210 

    Two hundred eighty-one alcoholic patients were prospectively evaluated by clinical, biochemical, and histologic parameters during a 4-yr period to assess their prognosis. They were stratified into four categories of injury; 1) fatty liver (26 patients), 2) acute alcoholic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics